Author

Ash K. Bahl

University College DublinORCID 0009-0004-4316-546XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:protein structure· 1

Frequent Co-Authors

Simak AliiD· 2 shared Abhay KotechaiD· 1 shared Adrian F. Koh· 1 shared Alice Ormrod· 1 shared Anabel Varela‐Carver· 1 shared Basil J. GreberiD· 1 shared Charlotte Lynne BevaniD· 1 shared Chun‐Fui LaiiD· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Simak AliORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologyBritish Journal of CancerPeer-reviewedApr 19, 2023

The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer

Theodora A. Constantin, Anabel Varela‐Carver, Kyle K. Greenland…·Charlotte Lynne Bevan

This study investigates the antitumour activity of CT7001, a CDK7 inhibitor, in castration-resistant prostate cancer models, showing it inhibits proliferation and enhances enzalutamide efficacy.

29 citationstop 3%

humanexperimental assay

𝕏 PostBluesky

Molecular BiologybioRxivPreprintApr 7, 2023

High-resolution cryo-electron microscopy of the human CDK-activating kinase for structure-based drug design

Victoria I. Cushing, Adrian F. Koh, Junjie Feng…·Basil J. Greber

The paper determines high-resolution structures of CDK-activating kinase using cryo-EM, revealing inhibitor interactions and providing a framework for structure-based drug design.

4 citations

humanprotein structure

𝕏 PostBluesky